CEACAM5 and gastric cancer: To determine whether ST3Gal IV and CEA (CEACAM5) expression have an impact on survival in GC patients, we extended our studies to a large independent, publicly available microarray data set of 882 patients (Kaplan-Meier Plotter 32 (http://www.kmplot.com/).